rheumatology
ASAS Criteria for Axial Spondyloarthritis (Axial SpA)
Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial SpA in patients with chronic back pain ≥3 months onset age <45 years. Includes radiographic (AS) and non-radiographic axial SpA.
References
- Rudwaleit M et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis. Ann Rheum Dis. 2009;68(6):777–783.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Dapsone · Anti-inflammatory / Antimicrobial
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Methoxyflurane · Inhaled Analgesic — Acute Pain
- Diclofenac · Non-Steroidal Anti-Inflammatory Drug (NSAID)
- Colchicine (Acute Gout) · Anti-Inflammatory (Microtubule Inhibitor)
- Diclofenac · NSAID (Non-Steroidal Anti-Inflammatory Drug)
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.